Speech-Language Pathologists in Newberry, SC Accepting Medicare

8 Speech-Language Pathologists found. Showing 1 - 8

Candice Keim, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 231 Fairway Dr, Newberry, SC 29108 Phone: 866-425-5768    Fax: 888-308-1147

School District Of Newberry County Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1406 Boundary St, Newberry, SC 29108 Phone: 803-321-2616    Fax: 803-321-2605

Newberry County School District Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1539 Martin St, Newberry, SC 29108 Phone: 803-321-2600    Fax: 803-321-2013

Mrs. Cara Morris, SLT Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3605 Spearman Rd, Newberry, SC 29108 Phone: 803-321-2664

Miss Daja Delilah Riggins, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2555 Kinard St, Newberry, SC 29108 Phone: 803-276-6060

Lindsay Wilhelm, MSP CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1028 Crosshill Ln, Newberry, SC 29108 Phone: 803-361-6805

Mrs. Becky Bedenbaugh Mcglohorn Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1829 Nance St, Newberry, SC 29108 Phone: 803-321-2670

Rayshonda Perry, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2555 Kinard St, Newberry, SC 29108 Phone: 803-276-6060

News Archive

Simcere Pharmaceutical Group signs agreement to acquire manufacturing license from Tianjin Tianda Pharmaceutical

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced an agreement to acquire the manufacturing license in China of Rosuvastatin from Tianjin Tianda Pharmaceutical Co., Ltd. ("Tianda").

One in 20 children still receiving codeine to treat pain despite warning from federal regulators

A new study shows as many as one in 20 children were still receiving codeine to treat pain after tonsil and adenoid surgery, two years after federal regulators warned doctors that prescribing the opioid to kids after the routine surgeries could be fatal.

Discovery could have far-reaching implications for diagnosis and treatment of diabetic retinopathy

Indiana University researchers have detected new early-warning signs of the potential loss of sight associated with diabetes. This discovery could have far-reaching implications for the diagnosis and treatment of diabetic retinopathy, potentially impacting the care of over 25 million Americans.

Omega-3 PUFA biomarkers demonstrate benefits for fatal CHD

Regular consumption of seafood and plant-based omega-3 polyunsaturated fatty acids could help lower the risk of fatal coronary heart disease, confirm findings from a pooled analysis of 19 studies.

Abviva receives Japanese patent for Mammastatin Serum Assay

Abviva, Inc., a biomedical company engaged in the development and commercialization of breast cancer related applications of Mammastatin, announced today that the Japanese Patent Office issued two patents on the core technology that may be used for therapeutic applications and in the Company's breast cancer risk assessment test, the Mammastatin Serum Assay (MSA).

Read more Medical News

› Verified 8 days ago